{
    "clinical_study": {
        "@rank": "104295", 
        "arm_group": [
            {
                "arm_group_label": "Mutation Carriers", 
                "description": "Ajmaline challenge 1mg/kg in 5 minutes Whole-exome sequencing Dermal biopsy"
            }, 
            {
                "arm_group_label": "Non-Mutation Carriers", 
                "description": "Whole-exome sequencing"
            }
        ], 
        "brief_summary": {
            "textblock": "In a large Dutch SCN5A founder population with malignant ventricular arrhythmias, the\n      investigators aim to identify genetic modifiers by means of whole-exome sequencing and to\n      establish a comprehensive genotype-phenotype correlation, focussing on clinical and cellular\n      electrophysiological characteristics and neurocardiac modulation."
        }, 
        "brief_title": "Worm Study: Modifier Genes in Sudden Cardiac Death", 
        "condition": [
            "Brugada Syndrome", 
            "Long QT Syndrome 3"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Long QT Syndrome", 
                "Death, Sudden, Cardiac", 
                "Death", 
                "Brugada Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria (mutation carrier group):\n\n          -  Age > 18 years.\n\n          -  Confirmed kinship by haplotype analysis using predefined microsatellite markers.\n\n          -  Heterozygous or homozygous presence of the SCN5A delPhe1617 mutation.\n\n          -  Any SCN5A H588 variant (wild type, H558R-heterozygous or homozygous).\n\n          -  Written informed consent.\n\n        Inclusion Criteria (non-mutation carrier group):\n\n          -  Age > 18 years.\n\n          -  Confirmed kinship by haplotype analysis using predefined microsatellite markers.\n\n          -  Both parents of a mutation carrier can be included.\n\n          -  SCN5A wild type.\n\n          -  Any SCN5A H588 variant (wild type, H558R-heterozygous or homozygous).\n\n          -  Written informed consent.\n\n        Exclusion Criteria:\n\n          -  Age < 18 years.\n\n          -  Non-SCN5A delPhe1617 mutation or SCN5A wild type.\n\n          -  No confirmed kinship to founder population.\n\n          -  Inability or declination to give informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Dutch founder population with SCN5A mutation."
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014961", 
            "org_study_id": "METC 13-1-001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Mutation Carriers", 
                    "Non-Mutation Carriers"
                ], 
                "intervention_name": "Dermal biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Mutation Carriers", 
                "intervention_name": "Ajmaline challenge", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Mutation Carriers", 
                    "Non-Mutation Carriers"
                ], 
                "intervention_name": "Whole-exome sequencing", 
                "intervention_type": "Genetic"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ajmaline"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 26, 2014", 
        "location": {
            "contact": {
                "email": "rachel.ter.bekke@mumc.nl", 
                "last_name": "ter Bekke", 
                "phone": "+31433877098"
            }, 
            "facility": {
                "address": {
                    "city": "Maastricht", 
                    "country": "Netherlands", 
                    "state": "Limburg", 
                    "zip": "6202 AZ"
                }, 
                "name": "Maastricht University Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "2", 
        "official_title": "Worm Study: Identification of Modifier Genes in a Unique Founder Population With Sudden Cardiac Death", 
        "overall_contact": {
            "email": "rachel.ter.bekke@mumc.nl", 
            "last_name": "Rachel M.A. ter Bekke, M.D.", 
            "phone": "+31433877098"
        }, 
        "overall_contact_backup": {
            "email": "p.volders@maastrichtuniversity.nl", 
            "last_name": "Paul G.A. Volders, M.D., Ph.D.", 
            "phone": "+31433877097"
        }, 
        "overall_official": {
            "affiliation": "Maastricht University Medical Centre", 
            "last_name": "Paul G.A. Volders, M.D., Ph.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "The Netherlands: The Central Committee on Research Involving Human Subjects", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2024", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Difference in genetic profile (e.g. modifier genes) between mutation carriers expressing different phenotypes and non-mutation carriers.", 
            "safety_issue": "No", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014961"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Maastricht University Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Netherlands Heart Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Maastricht University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}